Search

Your search keyword '"Escalante Saavedra, Pamela Alejandra"' showing total 9 results
Start Over Author "Escalante Saavedra, Pamela Alejandra"
9 results on '"Escalante Saavedra, Pamela Alejandra"'

2. O isolamento social para prevenção da Covid-19 pode aumentar o risco de queimaduras no domicílio.

Author

Escalante Saavedra, Pamela Alejandra, da Silva Soares, Letícia Santana, Umaña Rivas, Mariel, and Galato, Dayani

Subjects
*COVID-19 pandemic, *HAND care & hygiene, *ISOPROPYL alcohol, *FOOD handling, *ASEPSIS & antisepsis
Abstract

Background: During the Covid-19 pandemic, the use of alcohol at 70° GL was widely recommended for hand and surface hygiene. Combined with greater permanency of individuals in the household, this recommendation may contribute to an increased risk of burns. Objective: To outline the risks of burns in the context of the pandemic. Method: A review through document analysis was carried out. Results: Liquid alcohol 70° GL and isopropyl alcohol 70° GL are substances that present a greater risk of ignition during use and storage. Alcohol 70° GL in gel should be prioritized both for its greater easier of use for hand antisepsis and for its lower risk of flammability. These materials must not be handled during food preparation. Conclusion: Health and government authorities must be responsible for disseminating the necessary care to prevent burns and fires in the context of the pandemic. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

4. Transplante de células-tronco hematopoiéticas: iniquidades na distribuição em territorio brasileiro, 2001 a 2020.

Author

Magedanz, Lucas, de Oliveira Leal, Jessica Vick, dos Santos, Brenda Leandro, de Brito, Evelin Soares, Escalante Saavedra, Pamela Alejandra, da Silva Soares, Letícia Santana, Lima D'Oliveira, Letícia da Costa, and Galato, Dayani

Subjects
BONE marrow cells, HEALTH services accessibility, TRANSPLANTATION of organs, tissues, etc., HOSPITALS, WAREHOUSES
Abstract

Copyright of Revista Ciência & Saúde Coletiva is the property of Associacao Brasileira de Pos-Graduacao em Saude Coletiva and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2022
Full Text
View/download PDF

5. Tratamiento farmacológico para COVID-19 en protocolos latinoamericanos: una revisión narrativa de la eficacia y seguridad

Author

Escalante Saavedra, Pamela Alejandra, Cañás, Martín, Calvo Barbado, Dulce María, Barajas Esparza, Liliana, Caffaratti, Mariana, Speranza, Noelia, Fuentes Martínez, Carlos, and López Guitiérrez, José Julián

Subjects
Aislamiento social, Pandemia, SARS-CoV-2, Clinical protocols, COVID-19, Cuarentena, Coronavirus, Latin America, Medicina basada en evidencia, Evidence based medicine, Protocolos clínicos, Medicamentos, Latinoamérica, Emergencia sanitaria, Medicaments
Abstract

La pandemia causada por el SARS-Cov-2 ha puesto a la comunidad científica mundial en ritmo acelerado de investigación y busca por un tratamiento efectivo para COVID-19. Objetivo:Identificar y evaluar medicamentos en protocolos latinoamericanos de tratamiento farmacológico para el COVID-19. Método: Se analiza la evidencia y resultados de mega ensayo disponibles hasta la fecha sobre los medicamentos más frecuentes. Resultados: Los medicamentos más frecuentes en protocolos nacionales son hidroxicloroquina, lopinavir/ritonavir y remdesivir. Ninguno de los medicamentos que recopilan mayor cantidad de datos provenientes de estudios clínicos, a excepción de la dexametasona en un subgrupo reducido de pacientes, mostró, hasta el momento, diferencias significativas en la mortalidad. Conclusiones: La situación emergente de la COVID-19 ha determinado la toma de decisiones apresuradas y controversiales con base en estudios cuestionables y/o de baja calidad. Esto pone de relieve el carácter provisorio de la información y la posibilidad de generar cambios a medida que se dispongan de más resultados. La autorización anticipada de medicamentos expone un problema conocido. A pesar de que la agilidad regulatoria es necesaria en este momento, la velocidad no debe sobreponerse a los patrones básicos éticos y de confianza en la evidencia. The pandemic caused by SARS-CoV-2 has put the global scientific community in an accelerated pace of research for an effective treatment for COVID-19. Objective:To identify and evaluate drugs in Latin American protocols of pharmacological treatment for COVID-19. Method: The evidence and mega trial results available to date on the most frequent medications are analyzed. Results: The most common drugs in national protocols are hydroxychloroquine, lopinavir/ritonavir, and remdesivir. None of the drugs that collect the most data from clinical studies, with the except for dexamethasone in a small subgroup of patients, so far showed significant differences in mortality. Conclusions: The emerging situation of COVID-19 has determined hasty and controversial decision-making based on questionable and/or low-quality studies. This highlights the provisional nature of the information and the possibility of generating changes as more results become available. Advance medication authorization exposes a known problem. Although regulatory agility is required at this time, speed should not overlap with basic ethical standards and trust in evidence. publishedVersion Fil: Escalante Saavedra, Pamela Alejandra. Conselho Federal de Farmácia. Centro Brasileiro de Informação sobre Medicamentos Brasília; Brasil. Fil: Cañás Martín. Federación Médica de la Provincia de Buenos Aires. CIMEFF Área de Farmacología; Argentina. Fil: Calvo Barbado, Dulce María. España. Fil: Barajas Esparza; Liliana. Universidad Autónoma del Estado de Hidalgo. Instituto de Ciencias de la Salud; México. Fil: Caffaratti, Mariana. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Centro de Información de Medicamentos; Argentina. Fil: Speranza, Noelia. Universidad de la República. Facultad de Medicina. Departamento de Farmacología y Terapéutica; Uruguay. Fil: Fuentes, Martínez Carlos. Acción Internacional por la Salud. Centro de Información de Medicamentos; Nicaragua. Fil: López Guitiérrez, José Julián. Universidad Nacional de Colombia. Facultad de Ciencias. Departamento de Farmacia; Colombia.

Published
2020

6. Brazilian Drug Information Centre: descriptive study on the quality of information 2010-2015

Author

Escalante-Saavedra, Pamela Alejandra, Marques-Batista, Gabriela, Maniero, Hellen Karoline, Bedatt-Silva, Rachel, and Calvo-Barbado, Dulce María

Subjects
Rational use of medicines, Satisfacción del usuario, Drug Information Centre, User satisfaction, Centro de Información de Medicamentos, Uso racional de medicamentos
Abstract

Objective: To define the activities of the Drug Information Centre of the Federal Council of Pharmacy (Cebrim/FCP), to describe the passive information and the satisfaction of its users. Method: The centre has a computerized system for recording and storing the received questions and their answers: the Sistema de Informação Farmacoterapêutica SIFAR (Pharmacotherapeutical Information System) that generates management reports; out of these, the reports from the period 2010 to 2015 were analyzed. Results: The main activity carried out by the centre was the passive information provided to pharmacists and undergraduate Pharmacy students. The most frequent subjects were: administration and way of use of medicines and indication and drug interactions, which were answered in less than 24 hours in most cases. Approximately 80% of those users who completed the satisfaction survey rated the service provided as good and optimal. Conclusion: Cebrim/FCP provides objective, updated and timely information (passive information) on medicines for pharmacists, with administration and way of use as the most recurrent subjects, and the majority of applicants were satisfied with the service. Resumen Objetivo: Caracterizar las actividades del Centro de Información sobre Medicamentos del Consejo Federal de Farmacia (Cebrim/CFF), describir la información pasiva y la satisfacción de sus usuarios. Método: El centro cuenta con un sistema informatizado de registro y almacenamiento de preguntas y respuestas recibidas (Sistema de Informação Farmacoterapêutica SIFAR), que genera informes gerenciales, del cual fueron analizados los informes del período de 2010 a 2015. Resultados: La actividad principal realizada por el centro fue la información pasiva brindada a farmacéuticos y estudiantes de pregrado de Farmacia. Los temas más frecuentes fueron administración y modo de uso de los medicamentos e indicación e interacciones medicamentosas, con respuesta en menos de 24 h, en la mayoría de los casos. Entre los usuarios que cumplimentaron la encuesta de satisfacción, aproximadamente el 80% de los usuarios clasificaron el servicio brindado como bueno y óptimo. Conclusión: Cebrim/CFF brinda información objetiva, actualizada y oportuna (información pasiva) sobre medicamentos para profesionales farmacéuticos, con administración y modo de uso como temas más recurrentes, y la gran mayoría de los solicitantes están complacidos con el servicio.

Published
2017

7. Reações adversas em pacientes hospitalizados com doenças infecciosas

Author

Toledo, Maria Inês de, Escalante Saavedra, Pamela Alejandra, Toledo, Maria Inês de, and Escalante Saavedra, Pamela Alejandra

Abstract

Dissertação (mestrado)—Universidade de Brasília, Faculdade de Ciências da Saúde, Programa de Pós-Graduação em Ciências da Saúde, 2014., As reações adversas a medicamentos (RAM) constituem um problema de saúde pública por sua influência sobre as taxas de morbidade e mortalidade e sobre os custos de saúde. Neste estudo observacional retrospectivo buscou-se caracterizar as RAM ocorridas em adultos hospitalizados com doenças infecciosas no Hospital Universitário de Brasília e determinar a frequência, distribuição e classificação das suspeitas dessas reações, identificar a conduta adotada para seu manejo e a evolução clínica dos pacientes, descrever os medicamentos envolvidos nas reações, estabelecer relações de causalidade e identificar os fatores predisponentes às suspeitas de RAM. Foram incluídos pacientes com doenças infecciosas hospitalizados na clínica médica do hospital no período de março de 2013 a março de 2014. Para diagnóstico de RAM, adotou-se a definição proposta pela Organização Mundial da Saúde (OMS). As reações foram identificadas nos formulários de notificação de suspeita de reações adversas e nas fichas de seguimento farmacoterapêutico e prontuários dos pacientes. Adicionalmente, foram revisados os resultados laboratoriais, as prescrições e os relatórios de dispensação de antirretrovirais, quando aplicáveis, para complementação das informações de uso de medicamentos. As descrições das suspeitas de RAM foram harmonizadas de acordo com a Terminologia de Reações Adversas da OMS. As suspeitas de reações foram classificadas, de acordo com Rawlins e Thompson, em tipo A e tipo B. Utilizou-se o algoritmo de Naranjo para estabelecer causalidades. Os medicamentos envolvidos nas suspeitas de RAM foram categorizados segundo a classificação Anatomical Therapeutic Chemical (ATC). Realizou-se análise estatística bivariada para comparar pacientes com RAM e sem RAM quanto a idade, sexo, diagnóstico de aids, terapia antirretroviral (TARV), tempo de hospitalização, reinternação, mudança de nível de complexidade de tratamento, presença de alergia e óbito. Empregou-se a razão de chances (odds ratio, OR) com, Adverse drug reactions (ADRs) constitute a public-health problem, given their high morbidity and mortality rates and the increased healthcare costs incurred. This observational, retrospective study sought to describe ADRs that affected adult patients hospitalized for infectious diseases in the Hospital Universitário de Brasília, a teaching hospital located in Brazil’s capital city, classify suspected ADRs and determine their frequency and distribution, identify the approach adopted for its management and the clinical outcomes, describe the drugs implicated, establish causal links, and identify factors that predisposed to suspected ADRs. The study included patients hospitalized for infectious diseases at the hospital’s medical clinic from March 2013 to March 2014. ADR diagnosis was based on the definition proposed by the World Health Organization (WHO). Cases were identified by reviewing the reporting forms for suspected ADRs, drug therapy follow-up charts, and medical records. Additional data on drug use were collected by reviewing laboratory findings, prescriptions, and antiretroviral dispensing reports (when applicable). The descriptions of suspected ADRs were harmonized with the WHO Adverse Drug Reaction Terminology. The suspected reactions were categorized as type A and type B, according to Rawlins and Thompson’s criteria. The Naranjo algorithm was employed to establish causal links. The Anatomical Therapeutic Chemical (ATC) classification was applied to categorize the drugs implicated in suspected cases. Bivariate statistical analysis was performed to compare patients with and without ADRs. The variables considered were age, sex, diagnosis of AIDS, antiretroviral therapy (ART), length of hospital stay, readmission, changes in treatment complexity level, presence of allergies, and death. Odds ratio was used as a measure of association, with a confidence interval of 95% and a significance level of 5% (p < 0.05). Of the 113 patients included in the study, 13 (11.5

Published
2015

9. Brazilian Drug Information Centre: descriptive study on the quality of information 2010-2015.

Author

Escalante-Saavedra PA, Marques-Batista G, Maniero HK, Bedatt-Silva R, and Calvo-Barbado DM

Subjects
Brazil, Consumer Behavior, Humans, Information Management, Medication Therapy Management, Pharmacists, Pharmacy Service, Hospital, Drug Information Services standards
Abstract

Objective: To define the activities of the Drug Information Centre of the Federal Council of Pharmacy (Cebrim/FCP), to describe the passive information and the satisfaction of its users., Method: The centre has a computerized system for recording and storing the received questions and their answers: the Sistema de Informação Farmacoterapêutica SIFAR (Pharmacotherapeutical Information System) that generates management reports; out of these, the reports from the period 2010 to 2015 were analyzed., Results: The main activity carried out by the centre was the passive information provided to pharmacists and undergraduate Pharmacy students. The most frequent subjects were: administration and way of use of medicines and indication and drug interactions, which were answered in less than 24 hours in most cases. Approximately 80% of those users who completed the satisfaction survey rated the service provided as good and optimal., Conclusion: Cebrim/FCP provides objective, updated and timely information (passive information) on medicines for pharmacists, with administration and way of use as the most recurrent subjects, and the majority of applicants were satisfied with the service., (Copyright AULA MEDICA EDICIONES 2017. Published by AULA MEDICA. All rights reserved.)

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results